| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/14/2007 | CN1304010C Ribavirin inhalation powder atomizing agent and its preparing process |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304008C Medical compsns. |
| 03/14/2007 | CN1304007C Application of acetyl boswellic acid in preparing antitumor agent |
| 03/14/2007 | CN1304006C Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/14/2007 | CN1304004C Local use medicinal composition |
| 03/14/2007 | CN1304003C Colon positioning and adhering preparation and its preparing process |
| 03/14/2007 | CN1304002C Vaginal effervescence tablet of secnidazole and its preparation |
| 03/14/2007 | CN1304001C Nitroimidazole external preparations for dermatosis |
| 03/14/2007 | CN1304000C Use of valsartan in preparing drug for treating lung cancer |
| 03/14/2007 | CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 03/14/2007 | CN1303998C Pharmaceutical formulations containing darifenacin |
| 03/14/2007 | CN1303997C Method for preparing artemisine and its liposoluble derivatives emulsion |
| 03/14/2007 | CN1303996C use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 03/14/2007 | CN1303995C Use of alpine yarrow herb effective parts in preparing medicine for respiratory tract virus |
| 03/14/2007 | CN1303994C Taxol vesicle injection and its prepn |
| 03/14/2007 | CN1303993C Soft capsule preparation |
| 03/14/2007 | CN1303992C Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 03/14/2007 | CN1303991C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative and process for preparing the same |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303989C Zinc gluconate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303988C External skin preparations for suppressing sebum secretion |
| 03/14/2007 | CN1303987C Esmolol Hydrochloride freeze dried powder for injection and its preparation method |
| 03/14/2007 | CN1303986C Patch |
| 03/14/2007 | CN1303982C Antifungal agent and preparation and use method |
| 03/14/2007 | CN1303980C Orally quick releasing tablet of compound red sage root, its medical uses and preparation process |
| 03/14/2007 | CN1303967C Oral hygienic product with melatonin alkali as active substance to supply human and animal use |
| 03/14/2007 | CN1303953C Composition for acceleration of wound and burn healing and wound and burn healing dressing |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189870 Cardiovascular disorders; antiinflammatory agents |
| 03/13/2007 | US7189865 Thiomolybdate analogues and uses thereof |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
| 03/13/2007 | US7189859 Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives |
| 03/13/2007 | US7189856 Central nervous system disorders; vision defects; antiproliferative agents |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189853 Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts |
| 03/13/2007 | US7189851 Condensed heterocyclic compounds as calcitonin agonists |
| 03/13/2007 | US7189849 Synthesis of acyclic nucleoside derivatives |
| 03/13/2007 | US7189828 use of glycopeptides containing sulfated tyrosines and sialyated, fucosylated N-acetyllactosamino glycans; for treating inflammation, ischemia-reperfusion injury, rheumatoid arthritis, atherosclerosis, leukocyte-mediated lung injury, restenosis, and thrombosis |
| 03/13/2007 | US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 03/13/2007 | US7189800 Forming vaccines; analyzing hemagglutinin, calibration |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189760 Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine |
| 03/13/2007 | US7189759 Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189757 Sleep disorders; side effect reduction |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189753 Preemptive prophylaxis of migraine |
| 03/13/2007 | US7189752 Anticancer agents |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189750 Bis-[4-methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-amine for example; use to treat nitric oxide (NO)-mediated diseases such as cardiovascular diseases, inflammation, tumor suppression and psychiatric and neurological diseases; natural metabolite formed when NO is released, side effect reduction |
| 03/13/2007 | US7189749 Substituted phenoxyacetic acids |
| 03/13/2007 | US7189748 Compounds and methods for treating insulin resistance and cardiomyopathy |
| 03/13/2007 | US7189747 Administering aminobutyric acid analog; bone disorders |
| 03/13/2007 | US7189746 Methods for promoting wound healing |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189744 Crystals of benzimidazole compounds |
| 03/13/2007 | US7189743 To inhibit thrombus formation |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189740 synergistic mixture of amino-1,3-dihydroisoindol-2-yl)piperidin-2,6-dione compound as immunomoderator and another active drug |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189737 Cocaine receptor binding ligands |
| 03/13/2007 | US7189736 Prodrugs of imidazopyridine derivatives |
| 03/13/2007 | US7189735 Use of CCI-779 as an antineoplastic agent |
| 03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 03/13/2007 | US7189733 Compositions and methods for inhibiting TGF-β |
| 03/13/2007 | US7189732 For therapy of, for example, transplant rejection, inflammatory bowel syndrome, rheumatoid arthritis, psoriasis, restenosis, allergic asthma, Alzheimer's disease, Parkinson, stroke, osteoporosis, cancer, and benign hyperplasia |
| 03/13/2007 | US7189731 2-amino-6-oxy-substituted pyrido[3,4d]pyrimidine derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis. |
| 03/13/2007 | US7189729 Methods and compositions as protein kinase inhibitors |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189726 Benzofuran derivatives as inhibitors of p38-α kinase |
| 03/13/2007 | US7189725 Administering (-)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol or a pharmaceutically acceptable salt thereof for reducing ischemic damage |
| 03/13/2007 | US7189724 For therapy of viral diseases |
| 03/13/2007 | US7189723 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
| 03/13/2007 | US7189721 Bicyclic protein kinase inhibitors |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses |
| 03/13/2007 | US7189717 Medicinal compositions promoting bowel movement |
| 03/13/2007 | US7189716 anticarcinogenic agents |
| 03/13/2007 | US7189715 Compositions comprising zopiclone derivatives and methods of making and using the same |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189712 For therapy of hyperproliferative diseases |
| 03/13/2007 | US7189711 Muscle relaxants; central nervous system disorders; Parkinson's disease; Alzheimer's disease; strokes |
| 03/13/2007 | US7189710 C2-fluoro pyrrolo [2,1−c][1,4]benzodiazepine dimers |
| 03/13/2007 | US7189708 Skin regeneration; antiwrinkle agents, antiaging agents |
| 03/13/2007 | US7189707 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and |
| 03/13/2007 | US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 03/13/2007 | US7189704 6-11 bicyclic ketolide derivatives |
| 03/13/2007 | US7189703 Treatment and diagnosis of alzheimer's disease |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |